English

EXACT SCIENCES CORPORATION

EDGAR

EXAS Current report (8-K) · filed 2026-02-20

Annual consolidated revenue for 2025: about USD 3.247B, using the latest reported figures. The previous period, 2024, was about USD 2.759B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

878 million USD

2025 Q4 · USD

Exact inputs and evidence

Revenue: 3246990000 USD Source
Revenue: 2368609000 USD Source

Operating margin

-9.4%

2025 Q4 · %

Exact inputs and evidence

Operating Income: -206298000 USD Source
Operating Income: -123703000 USD Source
Revenue: 3246990000 USD Source
Revenue: 2368609000 USD Source

Operating cash flow

152 million USD

2025 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 491438000 USD Source
Operating Cash Flow: 339749000 USD Source

Free cash flow

120 million USD

2025 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 491438000 USD Source
Operating Cash Flow: 339749000 USD Source
Capital Expenditure: 134656000 USD Source
Capital Expenditure: 103413000 USD Source

Cash and cash equivalents: 956 million USD 2025-12-31 Source
Exact value

955996000 USD
Long-term debt including current maturities: 23.8 million USD 2020-12-31 Source
Exact value

23750000 USD
Shares outstanding: 191 million shares 2025-12-31 Source
Exact value

190802322 shares

Reported share-count change

2.79% · 5.19 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

185616438 shares · 2024-12-31· Source
190802322 shares · 2025-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-02-20.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2020-12-31
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.7%

Prior period

USD 2.76 billion

2024-01-01 – 2024-12-31
Current period

USD 3.25 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

3246990000 − 2758867000 = 488123000 USD

2758867000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
3246990000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Year-over-year change in Revenue: 488123000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3246990000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1367409 Filing: 000112414026000011 Input fundies:Revenue: 2758867000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1368392 Filing: 000112414026000011
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 820.91 million

Prior period

−USD 1.03 billion

2024-01-01 – 2024-12-31
Current period

−USD 207.95 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-207949000 − -1028857000 = 820908000 USD

-1028857000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-207949000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Year-over-year change in Net income: 820908000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -207949000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1087502 Filing: 000112414026000011 Input fundies:NetIncome: -1028857000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1059137 Filing: 000112414026000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+133.4%

Prior period

USD 210.54 million

2024-01-01 – 2024-12-31
Current period

USD 491.44 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

491438000 − 210536000 = 280902000 USD

210536000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
491438000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Year-over-year change in Operating cash flow: 280902000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 491438000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1140646 Filing: 000112414026000011 Input fundies:OperatingCashFlow: 210536000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1141297 Filing: 000112414026000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-1%

Prior period

USD 135.99 million

2024-01-01 – 2024-12-31
Current period

USD 134.66 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

134656000 − 135989000 = -1333000 USD

135989000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
134656000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Year-over-year change in Capital expenditure: -1333000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 134656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147402 Filing: 000112414026000011 Input fundies:CapitalExpenditure: 135989000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147990 Filing: 000112414026000011
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 3.25 billion 100% of revenue
Cost of revenue USD 984.24 million 30% of revenue
Operating expenses USD 2.47 billion 76% of revenue
Operating income −USD 206.3 million −6.4% of revenue
Tax, interest and other Derived USD 1.65 million 0.1% of revenue
Net income −USD 207.95 million −6.4% of revenue

Cash

Operating cash flow USD 491.44 million 15% of revenue
Capital expenditure USD 134.66 million 4.1% of revenue
Free cash flow Derived USD 356.78 million 11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 144% of revenue.
2018 Operating loss: operating costs were 135% of revenue.
2019 Operating loss: operating costs were 127% of revenue.
2020 Operating loss: operating costs were 151% of revenue.
2021 Operating loss: operating costs were 148% of revenue.
2022 Operating loss: operating costs were 128% of revenue.
2023 Operating loss: operating costs were 109% of revenue.
2024 Operating loss: operating costs were 138% of revenue.
2025 Operating loss: operating costs were 106% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	265989000	384299000 Derived	-118310000	-3913000 Derived	-114397000	-120204000 Derived	Source 2017-01-01 – 2017-12-31: 265989000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -118310000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -114397000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -71724000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 48480000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	454462000	613933000 Derived	-159471000	15678000 Derived	-175149000	-219033000 Derived	Source 2018-01-01 – 2018-12-31: 454462000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -159471000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -175149000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -68940000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 150093000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	876293000	1110075000 Derived	-233782000	-20692000 Derived	-213090000	-284309000 Derived	Source 2019-01-01 – 2019-12-31: 876293000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -233782000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -213090000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -111655000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 172654000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1491391000	2259087000 Derived	-767696000	55909000 Derived	-823605000	71404000 Derived	Source 2020-01-01 – 2020-12-31: 1491391000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -767696000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -823605000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 136482000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 65078000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1767087000	2622765000 Derived	-855678000	-260053000 Derived	-595625000	-238002000 Derived	Source 2021-01-01 – 2021-12-31: 1767087000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -855678000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -595625000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -102236000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 135766000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	2084279000	2677790000 Derived	-593511000	29995000 Derived	-623506000	-438021000 Derived	Source 2022-01-01 – 2022-12-31: 2084279000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -593511000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -623506000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -223559000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 214462000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	2499766000	2714778000 Derived	-215012000	-10863000 Derived	-204149000	31929000 Derived	Source 2023-01-01 – 2023-12-31: 2499766000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -215012000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -204149000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 156119000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 124190000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2758867000	3807570000 Derived	-1048703000	-19846000 Derived	-1028857000	74547000 Derived	Source 2024-01-01 – 2024-12-31: 2758867000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -1048703000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -1028857000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 210536000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 135989000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	3246990000	3453288000 Derived	-206298000	1651000 Derived	-207949000	356782000 Derived	Source 2025-01-01 – 2025-12-31: 3246990000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -206298000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -207949000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 491438000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 134656000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	265989000	Revenue: 265989000 Open source
20182018-12-31	Revenue	454462000	Revenue: 454462000 Open source
20192019-12-31	Revenue	876293000	Revenue: 876293000 Open source
20202020-12-31	Revenue	1491391000	Revenue: 1491391000 Open source
20212021-12-31	Revenue	1767087000	Revenue: 1767087000 Open source
20222022-12-31	Revenue	2084279000	Revenue: 2084279000 Open source
20232023-12-31	Revenue	2499766000	Revenue: 2499766000 Open source
20242024-12-31	Revenue	2758867000	Revenue: 2758867000 Open source
20252025-12-31	Revenue	3246990000	Revenue: 3246990000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 265989000 Open source
20182018-12-31	Year over year	70.9%	Revenue: 454462000 Open source Revenue: 265989000 Open source
20192019-12-31	Year over year	92.8%	Revenue: 876293000 Open source Revenue: 454462000 Open source
20202020-12-31	Year over year	70.2%	Revenue: 1491391000 Open source Revenue: 876293000 Open source
20212021-12-31	Year over year	18.5%	Revenue: 1767087000 Open source Revenue: 1491391000 Open source
20222022-12-31	Year over year	17.9%	Revenue: 2084279000 Open source Revenue: 1767087000 Open source
20232023-12-31	Year over year	19.9%	Revenue: 2499766000 Open source Revenue: 2084279000 Open source
20242024-12-31	Year over year	10.4%	Revenue: 2758867000 Open source Revenue: 2499766000 Open source
20252025-12-31	Year over year	17.7%	Revenue: 3246990000 Open source Revenue: 2758867000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6.4% 2025

Net margin -6.4% 2025

Free cash flow margin 11% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-44.5%	Operating Income: -118310000 Open source Revenue: 265989000 Open source
20182018-12-31	Operating margin	-35.1%	Operating Income: -159471000 Open source Revenue: 454462000 Open source
20192019-12-31	Operating margin	-26.7%	Operating Income: -233782000 Open source Revenue: 876293000 Open source
20202020-12-31	Operating margin	-51.5%	Operating Income: -767696000 Open source Revenue: 1491391000 Open source
20212021-12-31	Operating margin	-48.4%	Operating Income: -855678000 Open source Revenue: 1767087000 Open source
20222022-12-31	Operating margin	-28.5%	Operating Income: -593511000 Open source Revenue: 2084279000 Open source
20232023-12-31	Operating margin	-8.6%	Operating Income: -215012000 Open source Revenue: 2499766000 Open source
20242024-12-31	Operating margin	-38%	Operating Income: -1048703000 Open source Revenue: 2758867000 Open source
20252025-12-31	Operating margin	-6.4%	Operating Income: -206298000 Open source Revenue: 3246990000 Open source
20172017-12-31	Net margin	-43%	Net Income: -114397000 Open source Revenue: 265989000 Open source
20182018-12-31	Net margin	-38.5%	Net Income: -175149000 Open source Revenue: 454462000 Open source
20192019-12-31	Net margin	-24.3%	Net Income: -213090000 Open source Revenue: 876293000 Open source
20202020-12-31	Net margin	-55.2%	Net Income: -823605000 Open source Revenue: 1491391000 Open source
20212021-12-31	Net margin	-33.7%	Net Income: -595625000 Open source Revenue: 1767087000 Open source
20222022-12-31	Net margin	-29.9%	Net Income: -623506000 Open source Revenue: 2084279000 Open source
20232023-12-31	Net margin	-8.2%	Net Income: -204149000 Open source Revenue: 2499766000 Open source
20242024-12-31	Net margin	-37.3%	Net Income: -1028857000 Open source Revenue: 2758867000 Open source
20252025-12-31	Net margin	-6.4%	Net Income: -207949000 Open source Revenue: 3246990000 Open source
20172017-12-31	Free cash flow margin	-45.2%	Revenue: 265989000 Open source Operating Cash Flow: -71724000 Open source Capital Expenditure: 48480000 Open source
20182018-12-31	Free cash flow margin	-48.2%	Revenue: 454462000 Open source Operating Cash Flow: -68940000 Open source Capital Expenditure: 150093000 Open source
20192019-12-31	Free cash flow margin	-32.4%	Revenue: 876293000 Open source Operating Cash Flow: -111655000 Open source Capital Expenditure: 172654000 Open source
20202020-12-31	Free cash flow margin	4.8%	Revenue: 1491391000 Open source Operating Cash Flow: 136482000 Open source Capital Expenditure: 65078000 Open source
20212021-12-31	Free cash flow margin	-13.5%	Revenue: 1767087000 Open source Operating Cash Flow: -102236000 Open source Capital Expenditure: 135766000 Open source
20222022-12-31	Free cash flow margin	-21%	Revenue: 2084279000 Open source Operating Cash Flow: -223559000 Open source Capital Expenditure: 214462000 Open source
20232023-12-31	Free cash flow margin	1.3%	Revenue: 2499766000 Open source Operating Cash Flow: 156119000 Open source Capital Expenditure: 124190000 Open source
20242024-12-31	Free cash flow margin	2.7%	Revenue: 2758867000 Open source Operating Cash Flow: 210536000 Open source Capital Expenditure: 135989000 Open source
20252025-12-31	Free cash flow margin	11%	Revenue: 3246990000 Open source Operating Cash Flow: 491438000 Open source Capital Expenditure: 134656000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 491.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-71724000	Operating Cash Flow: -71724000 Open source
20182018-12-31	Operating cash flow	-68940000	Operating Cash Flow: -68940000 Open source
20192019-12-31	Operating cash flow	-111655000	Operating Cash Flow: -111655000 Open source
20202020-12-31	Operating cash flow	136482000	Operating Cash Flow: 136482000 Open source
20212021-12-31	Operating cash flow	-102236000	Operating Cash Flow: -102236000 Open source
20222022-12-31	Operating cash flow	-223559000	Operating Cash Flow: -223559000 Open source
20232023-12-31	Operating cash flow	156119000	Operating Cash Flow: 156119000 Open source
20242024-12-31	Operating cash flow	210536000	Operating Cash Flow: 210536000 Open source
20252025-12-31	Operating cash flow	491438000	Operating Cash Flow: 491438000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 356.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-120204000	Operating Cash Flow: -71724000 Open source Capital Expenditure: 48480000 Open source
20182018-12-31	Free cash flow	-219033000	Operating Cash Flow: -68940000 Open source Capital Expenditure: 150093000 Open source
20192019-12-31	Free cash flow	-284309000	Operating Cash Flow: -111655000 Open source Capital Expenditure: 172654000 Open source
20202020-12-31	Free cash flow	71404000	Operating Cash Flow: 136482000 Open source Capital Expenditure: 65078000 Open source
20212021-12-31	Free cash flow	-238002000	Operating Cash Flow: -102236000 Open source Capital Expenditure: 135766000 Open source
20222022-12-31	Free cash flow	-438021000	Operating Cash Flow: -223559000 Open source Capital Expenditure: 214462000 Open source
20232023-12-31	Free cash flow	31929000	Operating Cash Flow: 156119000 Open source Capital Expenditure: 124190000 Open source
20242024-12-31	Free cash flow	74547000	Operating Cash Flow: 210536000 Open source Capital Expenditure: 135989000 Open source
20252025-12-31	Free cash flow	356782000	Operating Cash Flow: 491438000 Open source Capital Expenditure: 134656000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

59% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Liabilities / assets	Not reported	No source recorded
20182018-12-31	Liabilities / assets	55.3%	Total Liabilities: 843081000 Open source Total Assets: 1524022000 Open source
20192019-12-31	Liabilities / assets	34.7%	Total Liabilities: 1217707000 Open source Total Assets: 3505768000 Open source
20202020-12-31	Liabilities / assets	54.6%	Total Liabilities: 2689539000 Open source Total Assets: 4925092000 Open source
20212021-12-31	Liabilities / assets	49.3%	Total Liabilities: 3297248000 Open source Total Assets: 6684884000 Open source
20222022-12-31	Liabilities / assets	51.1%	Total Liabilities: 3183711000 Open source Total Assets: 6226873000 Open source
20232023-12-31	Liabilities / assets	51.4%	Total Liabilities: 3326029000 Open source Total Assets: 6471334000 Open source
20242024-12-31	Liabilities / assets	59.5%	Total Liabilities: 3525890000 Open source Total Assets: 5928139000 Open source
20252025-12-31	Liabilities / assets	59%	Total Liabilities: 3459577000 Open source Total Assets: 5860629000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.43× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Current assets / current liabilities	Not reported	No source recorded
20182018-12-31	Current assets / current liabilities	9.02×	Current Assets: 1228067000 Open source Current Liabilities: 136169000 Open source
20192019-12-31	Current assets / current liabilities	2.34×	Current Assets: 553936000 Open source Current Liabilities: 236494000 Open source
20202020-12-31	Current assets / current liabilities	3.47×	Current Assets: 2198594000 Open source Current Liabilities: 633095000 Open source
20212021-12-31	Current assets / current liabilities	2.76×	Current Assets: 1426237000 Open source Current Liabilities: 517068000 Open source
20222022-12-31	Current assets / current liabilities	2.38×	Current Assets: 982257000 Open source Current Liabilities: 412747000 Open source
20232023-12-31	Current assets / current liabilities	2.32×	Current Assets: 1194369000 Open source Current Liabilities: 514701000 Open source
20242024-12-31	Current assets / current liabilities	2.15×	Current Assets: 1571423000 Open source Current Liabilities: 732187000 Open source
20252025-12-31	Current assets / current liabilities	2.43×	Current Assets: 1555849000 Open source Current Liabilities: 641152000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 114.4 million Exact value Exact value: -114397000 USD 2017-01-01 – 2017-12-31: -114397000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2017-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -114397000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -114397000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414020000010/exas-20191231.htm#1582465 Filing: 000112414020000010 The citation records this snapshot. The page link may show a newer release later.	−USD 71.72 million Exact value Exact value: -71724000 USD 2017-01-01 – 2017-12-31: -71724000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2017-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: -71724000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -71724000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414020000010/exas-20191231.htm#1872148 Filing: 000112414020000010 The citation records this snapshot. The page link may show a newer release later.	USD 48.48 million Exact value Exact value: 48480000 USD 2017-01-01 – 2017-12-31: 48480000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2017-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 48480000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48480000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414020000010/exas-20191231.htm#1885532 Filing: 000112414020000010 The citation records this snapshot. The page link may show a newer release later.	−USD 120.2 million Calculation and evidence -71724000 − 48480000 USD Exact free cash flow: -120204000 USD 2017-01-01 – 2017-12-31: -71724000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 48480000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2017-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: -120204000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -71724000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414020000010/exas-20191231.htm#1872148 Filing: 000112414020000010 Input fundies:CapitalExpenditure: 48480000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414020000010/exas-20191231.htm#1885532 Filing: 000112414020000010 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 175.15 million Exact value Exact value: -175149000 USD 2018-01-01 – 2018-12-31: -175149000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2018-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -175149000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -175149000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414021000029/exas-20201231.htm#1283076 Filing: 000112414021000029 The citation records this snapshot. The page link may show a newer release later.	−USD 68.94 million Exact value Exact value: -68940000 USD 2018-01-01 – 2018-12-31: -68940000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2018-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: -68940000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68940000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414021000029/exas-20201231.htm#1477902 Filing: 000112414021000029 The citation records this snapshot. The page link may show a newer release later.	USD 150.09 million Exact value Exact value: 150093000 USD 2018-01-01 – 2018-12-31: 150093000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2018-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 150093000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 150093000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414021000029/exas-20201231.htm#1488044 Filing: 000112414021000029 The citation records this snapshot. The page link may show a newer release later.	−USD 219.03 million Calculation and evidence -68940000 − 150093000 USD Exact free cash flow: -219033000 USD 2018-01-01 – 2018-12-31: -68940000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 150093000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2018-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: -219033000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -68940000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414021000029/exas-20201231.htm#1477902 Filing: 000112414021000029 Input fundies:CapitalExpenditure: 150093000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414021000029/exas-20201231.htm#1488044 Filing: 000112414021000029 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 213.09 million Exact value Exact value: -213090000 USD 2019-01-01 – 2019-12-31: -213090000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2019-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -213090000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -213090000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414022000022/exas-20211231.htm#1271916 Filing: 000112414022000022 The citation records this snapshot. The page link may show a newer release later.	−USD 111.66 million Exact value Exact value: -111655000 USD 2019-01-01 – 2019-12-31: -111655000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2019-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: -111655000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -111655000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414022000022/exas-20211231.htm#1454683 Filing: 000112414022000022 The citation records this snapshot. The page link may show a newer release later.	USD 172.65 million Exact value Exact value: 172654000 USD 2019-01-01 – 2019-12-31: 172654000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2019-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 172654000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 172654000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414022000022/exas-20211231.htm#1464891 Filing: 000112414022000022 The citation records this snapshot. The page link may show a newer release later.	−USD 284.31 million Calculation and evidence -111655000 − 172654000 USD Exact free cash flow: -284309000 USD 2019-01-01 – 2019-12-31: -111655000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 172654000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2019-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: -284309000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -111655000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414022000022/exas-20211231.htm#1454683 Filing: 000112414022000022 Input fundies:CapitalExpenditure: 172654000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414022000022/exas-20211231.htm#1464891 Filing: 000112414022000022 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 823.61 million Exact value Exact value: -823605000 USD 2020-01-01 – 2020-12-31: -823605000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2020-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -823605000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -823605000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414023000014/exas-20221231.htm#1240238 Filing: 000112414023000014 The citation records this snapshot. The page link may show a newer release later.	USD 136.48 million Exact value Exact value: 136482000 USD 2020-01-01 – 2020-12-31: 136482000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2020-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: 136482000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 136482000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414023000014/exas-20221231.htm#1421588 Filing: 000112414023000014 The citation records this snapshot. The page link may show a newer release later.	USD 65.08 million Exact value Exact value: 65078000 USD 2020-01-01 – 2020-12-31: 65078000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2020-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 65078000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 65078000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414023000014/exas-20221231.htm#1431800 Filing: 000112414023000014 The citation records this snapshot. The page link may show a newer release later.	USD 71.4 million Calculation and evidence 136482000 − 65078000 USD Exact free cash flow: 71404000 USD 2020-01-01 – 2020-12-31: 136482000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 65078000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2020-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: 71404000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 136482000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414023000014/exas-20221231.htm#1421588 Filing: 000112414023000014 Input fundies:CapitalExpenditure: 65078000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414023000014/exas-20221231.htm#1431800 Filing: 000112414023000014 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 595.63 million Exact value Exact value: -595625000 USD 2021-01-01 – 2021-12-31: -595625000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2021-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -595625000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -595625000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000012/exas-20231231.htm#1048205 Filing: 000112414024000012 The citation records this snapshot. The page link may show a newer release later.	−USD 102.24 million Exact value Exact value: -102236000 USD 2021-01-01 – 2021-12-31: -102236000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2021-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: -102236000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -102236000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000012/exas-20231231.htm#1167468 Filing: 000112414024000012 The citation records this snapshot. The page link may show a newer release later.	USD 135.77 million Exact value Exact value: 135766000 USD 2021-01-01 – 2021-12-31: 135766000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2021-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 135766000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135766000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000012/exas-20231231.htm#1174166 Filing: 000112414024000012 The citation records this snapshot. The page link may show a newer release later.	−USD 238 million Calculation and evidence -102236000 − 135766000 USD Exact free cash flow: -238002000 USD 2021-01-01 – 2021-12-31: -102236000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 135766000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2021-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: -238002000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -102236000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000012/exas-20231231.htm#1167468 Filing: 000112414024000012 Input fundies:CapitalExpenditure: 135766000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000012/exas-20231231.htm#1174166 Filing: 000112414024000012 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 623.51 million Exact value Exact value: -623506000 USD 2022-01-01 – 2022-12-31: -623506000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2022-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -623506000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -623506000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414025000020/exas-20241231.htm#2433108 Filing: 000112414025000020 The citation records this snapshot. The page link may show a newer release later.	−USD 223.56 million Exact value Exact value: -223559000 USD 2022-01-01 – 2022-12-31: -223559000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2022-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: -223559000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -223559000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414025000020/exas-20241231.htm#1258984 Filing: 000112414025000020 The citation records this snapshot. The page link may show a newer release later.	USD 214.46 million Exact value Exact value: 214462000 USD 2022-01-01 – 2022-12-31: 214462000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2022-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 214462000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 214462000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414025000020/exas-20241231.htm#1265680 Filing: 000112414025000020 The citation records this snapshot. The page link may show a newer release later.	−USD 438.02 million Calculation and evidence -223559000 − 214462000 USD Exact free cash flow: -438021000 USD 2022-01-01 – 2022-12-31: -223559000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 214462000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2022-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: -438021000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -223559000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414025000020/exas-20241231.htm#1258984 Filing: 000112414025000020 Input fundies:CapitalExpenditure: 214462000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414025000020/exas-20241231.htm#1265680 Filing: 000112414025000020 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 204.15 million Exact value Exact value: -204149000 USD 2023-01-01 – 2023-12-31: -204149000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2023-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -204149000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -204149000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1030817 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 156.12 million Exact value Exact value: 156119000 USD 2023-01-01 – 2023-12-31: 156119000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2023-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: 156119000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 156119000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1141948 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 124.19 million Exact value Exact value: 124190000 USD 2023-01-01 – 2023-12-31: 124190000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2023-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 124190000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 124190000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1148575 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 31.93 million Calculation and evidence 156119000 − 124190000 USD Exact free cash flow: 31929000 USD 2023-01-01 – 2023-12-31: 156119000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 124190000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2023-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: 31929000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 156119000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1141948 Filing: 000112414026000011 Input fundies:CapitalExpenditure: 124190000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1148575 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 1.03 billion Exact value Exact value: -1028857000 USD 2024-01-01 – 2024-12-31: -1028857000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2024-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -1028857000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1028857000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1059137 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 210.54 million Exact value Exact value: 210536000 USD 2024-01-01 – 2024-12-31: 210536000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2024-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: 210536000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 210536000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1141297 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 135.99 million Exact value Exact value: 135989000 USD 2024-01-01 – 2024-12-31: 135989000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2024-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 135989000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135989000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147990 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 74.55 million Calculation and evidence 210536000 − 135989000 USD Exact free cash flow: 74547000 USD 2024-01-01 – 2024-12-31: 210536000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 135989000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2024-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: 74547000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 210536000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1141297 Filing: 000112414026000011 Input fundies:CapitalExpenditure: 135989000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147990 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 207.95 million Exact value Exact value: -207949000 USD 2025-01-01 – 2025-12-31: -207949000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Net Income: -207949000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -207949000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1087502 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 491.44 million Exact value Exact value: 491438000 USD 2025-01-01 – 2025-12-31: 491438000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Operating Cash Flow: 491438000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 491438000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1140646 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 134.66 million Exact value Exact value: 134656000 USD 2025-01-01 – 2025-12-31: 134656000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Capital Expenditure: 134656000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 134656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147402 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.	USD 356.78 million Calculation and evidence 491438000 − 134656000 USD Exact free cash flow: 356782000 USD 2025-01-01 – 2025-12-31: 491438000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 134656000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXACT SCIENCES CORPORATION · 2025-12-31 EXACT SCIENCES CORPORATION (edgar:1124140) Free cash flow: 356782000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:22Z Snapshot: fd4dd99f29f0f446349663eda87c2b871aba7df57b87c680cac5f6c75b287541 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124140?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 491438000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1140646 Filing: 000112414026000011 Input fundies:CapitalExpenditure: 134656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm#1147402 Filing: 000112414026000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

214 filings · 5,137 latest values · 5,137 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001124140, 1124140, EXAS, edgar:1124140

Also known as EXACT CORP, EXACT SCIENCES CORP, EXACT SCIENCES CORPORATION

EXACT SCIENCES CORPORATION

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation